# NHS Framework Agreement, Branded Medicines for London and South of England

> Contract award record from UK public-sector procurement sources.

## Key facts

- Public buyer: [NHS England](/buyers/nhs-england/contract-awards)
- Contract winner: Dr\.Reddy's Laboratories \(UK\) Limited
- Award value: £558,521,926
- Tender value: £441,994,547
- Award date: 19 August 2021
- Published: 17 September 2021
- Contract start: 1 September 2021
- Contract end: 31 August 2023
- Stage: awarded
- Procurement category: goods
- Notice ID: 87462943-eaf5-48e4-8e64-f87426d9c24c-469622
- OCID: ocds-b5fd17-16cf4518-7507-41cb-9c7e-596612c9998b

## Description

NHS Framework Agreement, Branded Medicines for London and South of England Offer reference number: CM/PHR/20/5598 FIND A TENDER \(FTS\) Reference number: FTS-002229 CM/PHR/20/5598/01 - NHS Framework for LONDON Branded Medicines - Tranche B\. Period of framework: 1 September 2021 to 31 August 2023 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months CM/PHR/20/5598/02 - NHS Framework for the LONDON Branded Medicines - Annual Tranche\. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 12 months CM/PHR/20/5598/03 - NHS Framework for the SOUTH of England Tranche A\. Period of Framework: 1 September 2021 to 31 August 2023 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 24 months CM/PHR/20/5598/04- NHS Framework for SOUTH of England - Tranche B\. Period of framework: 1 September 2021 to 31 August 2022 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 12 months CM/PHR/20/5598/05 - NHS Framework for the SOUTH of England Annual Tranche\. Period of Framework: 1 September 2021 to 31 August 2022 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 12 months CM/PHR/20/5598/06 - NHS Framework for the Midlands & East and North of England Regions - Bevacizumab Period of Framework: 1 September 2021 to 28 February 2022 with an option or options to extend \(at the Authority's discretion\) for a period or periods up to a total of 6 months

## Related contract awards

- [OutSystems licenses for MAPPTI \(AP&P\)](/contracts/ocds-b5fd17-521fbf90-6e93-4366-b3bc-47aa2efd447d): NHS England
- [Provision of national e-portfolio 26/27](/contracts/ocds-b5fd17-7e027849-39ea-4eb8-8eb0-3b38f18dcca4): NHS England
- [D&A Platform Run & Maintain](/contracts/ocds-b5fd17-58fe109d-49a3-4eea-957d-31f6bd69ff81): NHS England
- [CM/PHR/22/5687 - NHS National Proprietary Low Molecular Weight Heparins](/contracts/ocds-b5fd17-d50ab890-a60d-4303-954e-23b2becba9c2): NHS England

## Source

[View the original notice on Contracts Finder](https://www.contractsfinder.service.gov.uk/Notice/87462943-eaf5-48e4-8e64-f87426d9c24c-469622)